| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Division of Endocrinology and Metabolic Diseases, University of Verona Medical School, and Medical Department, GlaxoWellcome (S.U.), 37126 Verona, Italy
Address all correspondence and requests for reprints to: Prof. Enzo Bonora, Endocrinologia e Malattie del Metabolismo, Ospedale Civile Maggiore, Piazzale Stefani 1, 37126 Verona, Italy. E-mail: malmetab{at}borgotrento.univr.it
Antihypertensive treatment is frequently needed in type 2 diabetes. In
this study we measured the rates of total, oxidative, and nonoxidative
glucose disposal, glycogen synthesis, glycolysis, endogenous glucose
production, and lipid oxidation using a 4-h euglycemic (
5 mmol/L)
hyperinsulinemic (
300 pmol/L) clamp in combination with a dual
glucose tracer infusion ([3-3H]- and
[U-14C]D-glucose) and indirect calorimetry in
40 nonobese subjects with type 2 diabetes. Subjects were studied twice:
after a 4-week run-in period and after a 16-week period of double
blind, randomized treatment with 46 mg/day lacidipine, a calcium
channel blocker (n = 19), or 1020 mg/day lisinopril, an
angiotensin-converting enzyme inhibitor (n = 21). Antihypertensive
treatment resulted in a significant increase in total glucose disposal
during insulin clamp as well as in basal and insulin-stimulated
nonoxidative glucose disposal rates. On the contrary, oxidative glucose
disposal was significantly decreased by antihypertensive treatment,
mainly in the basal state. The changes in glucose disposal rates were
not significantly different in subjects treated with lacidipine and in
those treated with lisinopril. The suppression of endogenous glucose
production during insulin clamp was significantly greater after
lacidipine than after lisinopril.
These results suggest that treatment of subjects with type 2 diabetes with either lacidipine or lisinopril has no adverse effect on glucose metabolism. Conversely, both drugs seem to improve insulin sensitivity.
This article has been cited by other articles:
![]() |
P. Schling and G. Loffler Cross Talk Between Adipose Tissue Cells: Impact on Pathophysiology Physiology, June 1, 2002; 17(3): 99 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Targher, R. C. Bonadonna, M. Alberiche, M. B. Zenere, M. Muggeo, and E. Bonora Relation Between Soluble Adhesion Molecules and Insulin Sensitivity in Type 2 Diabetic Individuals: Role of adipose tissue Diabetes Care, November 1, 2001; 24(11): 1961 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bonora, G. Targher, M. Alberiche, R. C. Bonadonna, M. B. Zenere, F. Saggiani, and M. Muggeo Intracellular Partition of Plasma Glucose Disposal in Hypertensive and Normotensive Subjects with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2073 - 2079. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |